Patents by Inventor Omoefe Abugo

Omoefe Abugo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions comprising monitoring devices
    Publication number: 20050031536
    Abstract: Methods and compositions for the detection and monitoring of drug therapy are provided. In particular, efficient and sensitive methods for the detection of drug ingestion are provided for determining whether individuals are complying with prescribed therapeutic regimens, and for providing a mechanism for identifying drug-resistant strains of infectious agents. The claimed methods and compositions involve the application of transdermal devices containing detection mechanisms for receiving and recording signals generated by the ingestion of a labeled drug. Such devices are attached to the skin for the duration of drug therapy and compliance is determined either by direct reading, or by remote monitoring whereby signals are transmitted from the device and received at an external site such as a healthcare facility.
    Type: Application
    Filed: July 7, 2004
    Publication date: February 10, 2005
    Inventors: Zygmunt Gryczynski, Candace McCombs, Joseph Lakowicz, Omoefe Abugo
  • Devices and methods for monitoring drug therapy compliance
    Patent number: 6663846
    Abstract: Methods and compositions for the detection and monitoring of drug therapy are provided. In particular, efficient and sensitive methods for the detection of drug ingestion are provided for determining whether individuals are complying with prescribed therapeutic regimens, and for providing a mechanism for identifying drug-resistant strains of infectious agents. The claimed methods and compositions involve the application of transdermal devices containing detection mechanisms for receiving and recording signals generated by the ingestion of a labeled drug. Such devices are attached to the skin for the duration of drug therapy and compliance is determined either by direct reading, or by remote monitoring whereby signals are transmitted from the device and received at an external site such as a healthcare facility.
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: December 16, 2003
    Inventors: Candace McCombs, Joseph R. Lakowicz, Omoefe Abugo, Zygmunt Gryczynski